Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

CYP11B2

Reviewed April 2014

What is the official name of the CYP11B2 gene?

The official name of this gene is “cytochrome P450, family 11, subfamily B, polypeptide 2.”

CYP11B2 is the gene's official symbol. The CYP11B2 gene is also known by other names, listed below.

What is the normal function of the CYP11B2 gene?

The CYP11B2 gene provides instructions for making an enzyme called aldosterone synthase (previously known as corticosterone methyloxidase). This enzyme is found in the adrenal glands, which are located on top of the kidneys. Aldosterone synthase is a member of the cytochrome P450 family of enzymes. These enzymes are involved in the formation and breakdown of various molecules within cells.

Aldosterone synthase helps produce a hormone called aldosterone. Aldosterone helps control blood pressure by maintaining proper salt and fluid levels in the body. The aldosterone synthase enzyme is involved in a series of three chemical reactions that produce aldosterone from other (precursor) molecules: the conversion of 11-deoxycorticosterone to corticosterone, the conversion of corticosterone to 18-hydroxycorticosterone, and the conversion of 18-hydroxycorticosterone to aldosterone.

Does the CYP11B2 gene share characteristics with other genes?

The CYP11B2 gene belongs to a family of genes called CYP (cytochrome P450s).

A gene family is a group of genes that share important characteristics. Classifying individual genes into families helps researchers describe how genes are related to each other. For more information, see What are gene families? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genefamilies) in the Handbook.

How are changes in the CYP11B2 gene related to health conditions?

corticosterone methyloxidase deficiency - caused by mutations in the CYP11B2 gene

At least 30 CYP11B2 gene mutations that cause corticosterone methyloxidase deficiency (also known as aldosterone synthase deficiency) have been identified. These mutations lead to insufficient production of aldosterone, which impairs the kidneys' ability to reabsorb salt (sodium chloride or NaCl) into the blood and release potassium in the urine. As a result, excessive amounts of salt in the form of charged atoms (ions) of sodium (Na+) and chlorine (Cl-) leave the body in the urine, while not enough potassium is released. The resulting imbalance of ions in the body underlies the signs and symptoms of this disorder, which include nausea, vomiting, dehydration, low blood pressure, extreme tiredness (fatigue), and muscle weakness.

familial hyperaldosteronism - caused by mutations in the CYP11B2 gene

A genetic change affecting the CYP11B2 gene causes familial hyperaldosteronism type I, a disorder that leads to high blood pressure (hypertension). This change joins (fuses) the section of the CYP11B2 gene that contains the instructions for making aldosterone synthase to a section of a nearby gene called CYP11B1. The added part of the CYP11B1 gene contains a section called a promoter region, which normally helps start the production of an enzyme called 11-beta-hydroxylase from the CYP11B1 gene.

By binding to the CYP11B1 gene's promoter region, a hormone called adrenocorticotropic hormone (ACTH) normally triggers production of the 11-beta-hydroxylase enzyme. In the fusion gene, ACTH binding abnormally triggers production of aldosterone synthase. High levels of aldosterone synthase result in excessive aldosterone production, which leads to the hypertension associated with familial hyperaldosteronism type I.

other disorders - increased risk from variations of the CYP11B2 gene

Normal variations (polymorphisms) of the CYP11B2 gene have been associated with increased risk of cardiovascular problems including hypertension, stroke caused by a lack of blood flow to the brain (ischemic stroke), and a heart rhythm abnormality called atrial fibrillation in people with heart failure. Researchers suggest that differences in blood pressure control resulting from the CYP11B2 gene variations may lead to increased risk of these cardiovascular problems.

Where is the CYP11B2 gene located?

Cytogenetic Location: 8q21-q22

Molecular Location on chromosome 8: base pairs 142,910,557 to 142,917,861

The CYP11B2 gene is located on the long (q) arm of chromosome 8 between positions 21 and 22.

The CYP11B2 gene is located on the long (q) arm of chromosome 8 between positions 21 and 22.

More precisely, the CYP11B2 gene is located from base pair 142,910,557 to base pair 142,917,861 on chromosome 8.

See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.

Where can I find additional information about CYP11B2?

You and your healthcare professional may find the following resources about CYP11B2 helpful.

You may also be interested in these resources, which are designed for genetics professionals and researchers.

What other names do people use for the CYP11B2 gene or gene products?

  • ALDOS
  • aldosterone synthase
  • aldosterone-synthesizing enzyme
  • C11B2_HUMAN
  • CPN2
  • CYP11B
  • CYP11BL
  • CYPXIB2
  • cytochrome P450 11B2, mitochondrial
  • cytochrome P450 11B2, mitochondrial precursor
  • cytochrome P-450Aldo
  • cytochrome P-450C18
  • cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 2
  • mitochondrial cytochrome P450, family 11, subfamily B, polypeptide 2
  • P450aldo
  • P450C18
  • P-450C18
  • steroid 11-beta/18-hydroxylase
  • steroid 11-beta-monooxygenase
  • steroid 18-hydroxylase, aldosterone synthase, P450C18, P450aldo

See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.

What glossary definitions help with understanding CYP11B2?

adrenal glands ; aldosterone ; atrial ; atrial fibrillation ; breakdown ; cardiovascular ; chloride ; cytochrome P450 ; deficiency ; dehydration ; enzyme ; familial ; fibrillation ; fusion gene ; gene ; heart failure ; hormone ; hypertension ; ions ; Na ; NaCl ; potassium ; precursor ; promoter ; promoter region ; sodium ; sodium chloride

You may find definitions for these and many other terms in the Genetics Home Reference Glossary.

References

  • Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol. 2008 Aug 1;102(3):326-9. doi: 10.1016/j.amjcard.2008.03.063. Epub 2008 May 29. (http://www.ncbi.nlm.nih.gov/pubmed/18638595?dopt=Abstract)
  • Connell JM, Fraser R, MacKenzie SM, Friel EC, Ingram MC, Holloway CD, Davies E. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):243-7. Review. (http://www.ncbi.nlm.nih.gov/pubmed/15134824?dopt=Abstract)
  • OMIM: CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2 (http://omim.org/entry/124080)
  • Martinez-Aguayo A, Fardella C. Genetics of hypertensive syndrome. Horm Res. 2009;71(5):253-9. doi: 10.1159/000208798. Epub 2009 Apr 1. Review. (http://www.ncbi.nlm.nih.gov/pubmed/19339789?dopt=Abstract)
  • Moraitis AG, Rainey WE, Auchus RJ. Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension. Appl Clin Genet. 2013 Dec 24;7:1-13. doi: 10.2147/TACG.S35571. Review. (http://www.ncbi.nlm.nih.gov/pubmed/24399884?dopt=Abstract)
  • NCBI Gene (http://www.ncbi.nlm.nih.gov/gene/1585)
  • Nguyen HH, Hannemann F, Hartmann MF, Malunowicz EM, Wudy SA, Bernhardt R. Five novel mutations in CYP11B2 gene detected in patients with aldosterone synthase deficiency type I: Functional characterization and structural analyses. Mol Genet Metab. 2010 Aug;100(4):357-64. doi: 10.1016/j.ymgme.2010.04.016. Epub 2010 May 21. (http://www.ncbi.nlm.nih.gov/pubmed/20494601?dopt=Abstract)
  • Quack I, Vonend O, Rump LC. Familial hyperaldosteronism I-III. Horm Metab Res. 2010 Jun;42(6):424-8. doi: 10.1055/s-0029-1246187. Epub 2010 Feb 3. Review. (http://www.ncbi.nlm.nih.gov/pubmed/20131203?dopt=Abstract)
  • Stowasser M, Gordon RD. Familial hyperaldosteronism. J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29. Review. (http://www.ncbi.nlm.nih.gov/pubmed/11595502?dopt=Abstract)
  • White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):81-7. Review. (http://www.ncbi.nlm.nih.gov/pubmed/15134805?dopt=Abstract)
  • Williams SS. Advances in genetic hypertension. Curr Opin Pediatr. 2007 Apr;19(2):192-8. Review. (http://www.ncbi.nlm.nih.gov/pubmed/17496764?dopt=Abstract)
  • Yu Y. The CYP11B2 -344C/T variant is associated with ischemic stroke risk: An updated meta-analysis. J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):382-8. doi: 10.1177/1470320313492362. Epub 2013 Jun 7. (http://www.ncbi.nlm.nih.gov/pubmed/23748625?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: April 2014
Published: July 27, 2015